Similar Search Results

How Stronger Patent Protection in India Might Affect the Behavior of Transnational Pharmaceutical Industries

Fink, Carsten - 1999

affect India's pharmaceutical industry, Fink simulates the effects of introducing such protection - as required by the World … welfare. (India must amend its current patent regime by 2005 and establish a transitional regime in the meanwhile.) The model … groups, a subset of all available drugs was patent-protected in Western Europe but not India, where Indian manufacturers …

Persistent link: https://www.econbiz.de/10010524519

Intellectual property marketplaces and how they work : evidence from German pharmaceutical firms

Andersen, Birgitte; Rossi, Federica; Stephan, Johannes - In: Intereconomics : review of European economic policy 45 (2010) 1, pp. 35-47

This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...

Persistent link: https://www.econbiz.de/10009659550

Efficiency and its determinants : panel data evidence from the Indian pharmaceutical industry

Mahajan, Varun; Nauriyal, D. K.; Singh, S. P. - In: Margin: the journal of applied economic research 12 (2018) 1, pp. 19-40

Persistent link: https://www.econbiz.de/10011855216

Worldwide IP coverage of patented inventions in large pharma firms : to what extent do the internationalisation of R&D and firm strategy matter?

Laurens, Patricia; Le Bas, Christian; Schoen, Antoine - In: International journal of technology management : IJTM 80 (2019) 3/4, pp. 177-211

Persistent link: https://www.econbiz.de/10012107716

Product patents and access to medicines in India : a critical review of the implementation of TRIPS patent regime

Gopakumar, K. M. - In: Law and development review 3 (2010) 2, pp. 326-368

Persistent link: https://www.econbiz.de/10009624727

TRIPS implementation and secondary pharmaceutical patenting in Brazil and India

Sampat, Bhaven N.; Shadlen, Kenneth C. - In: Studies in comparative international development 50 (2015) 2, pp. 228-257

Persistent link: https://www.econbiz.de/10011486474

Efficiency evaluation of selected Indian pharmaceutical firms since inception of product patent

Bhattacharyya, Sucharita; Chatterjee, Susmita - In: International journal of management concepts and … 13 (2020) 4, pp. 292-318

Persistent link: https://www.econbiz.de/10012514629

The Indian Pharmaceutical Industry : Impact of Changes in the IPR Regime

Mitsumori, Yaeko - 2018

was ranked as No. 4 in the world in terms of volume and 15th in terms of value. WTO/TRIPS required India to revise its … patent law, however, and to introduce product patents in the pharmaceutical field. Many not only in India but also in the … introduction of a strong patent law. This study also covers recent developments in India regarding intellectual property rights and …

Persistent link: https://www.econbiz.de/10012396748

Domestic market competitiveness of Indian drug and pharmaceutical industry

Mahajan, Varun; Nauriyal, D. K.; Singh, S. P. - In: Review of managerial science : RMS 14 (2020) 3, pp. 519-559

Persistent link: https://www.econbiz.de/10012231338

Profitability determinants in Indian drugs and pharmaceutical industry : an analysis of pre and post TRIPS period

Tyagi, Shilpi; Nauriyal, D. K. - In: Eurasian journal of business and economics : EJBE 9 (2016) 17, pp. 1-21

Persistent link: https://www.econbiz.de/10011644031

1
2
3
4
5
6
7
8
9
10
Next
Last